Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years

de Carvalho Luiz Sergio F.; Campos Alessandra M.; Sposito Andrei C.

首页> 外文期刊>Diabetes care >Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years

【24h】

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years

机译：ProProtein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）抑制剂和入射2型糖尿病：系统审查和荟萃分析，具有超过96,000例患者 - 年

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE

机译：客观的

著录项

来源
《Diabetes care》 |2018年第2期|共4页
作者
de Carvalho Luiz Sergio F.; Campos Alessandra M.; Sposito Andrei C.;
展开▼
作者单位

Univ Estadual Campinas Cardiol Dept Campinas SP Brazil;

Univ Estadual Campinas Cardiol Dept Campinas SP Brazil;

Univ Estadual Campinas Cardiol Dept Campinas SP Brazil;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years [J] . de Carvalho Luiz Sergio F., Campos Alessandra M., Sposito Andrei C. Diabetes care . 2018,第2期

机译：ProProtein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）抑制剂和入射2型糖尿病：系统审查和荟萃分析，具有超过96,000例患者 - 年
2. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367 [J] . Cao Ye-Xuan, Li Jian-Jun Diabetes care . 2018,第4期

机译：Proprotein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）抑制剂和入射2型糖尿病：系统评价和荟萃分析超过96,000例患者年。糖尿病护理2018; 41：364-367
3. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367 [J] . de Carvalho Luiz Sergio F., Campos Alessandra M., Sposito Andrei C. Diabetes care . 2018,第4期

机译：Proprotein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）抑制剂和入射2型糖尿病：系统评价和荟萃分析超过96,000例患者年。糖尿病护理2018; 41：364-367
4. Towards Investigating the Role of Proprotein Convertase Subtilisin/Kexin Family (PCSK/7/9) in Cancer by Using Bioinformatics Motif Detection Technique [C] . Umar Draz, Sana Yasin, Shafiq Hussain, International Bhurban Conference on Applied Sciences and Technologies . 2021

机译：通过使用生物信息学主题检测技术来研究Proprotein转化酶枯草杆菌素/ kexin家族（PCSK / 7/9）的作用
5. Evaluation of the Interaction Between Proprotein Convertase Subtilisin/Kexin Type 9 and Sterol Carrier Protein-2 [D] . Ahranjani, Reza. 2017

机译：评价前蛋白转化酶枯草杆菌蛋白酶/ Kexin 9型与甾醇载体蛋白2的相互作用。
6. The Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Cardiovascular Homeostasis: A Non-Systematic Literature Review [O] . Ahmad Hachem, Essa Hariri, Perla Saoud, 2017

机译：前蛋白转化酶枯草杆菌蛋白酶/ Kexin 9型（PCSK9）在心血管稳态中的作用：非系统性文献综述
7. Comment on de Carvalho et al. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364–367 [O] . Ye-Xuan Cao, Jian-Jun Li 2018

机译：评论de carvalho等。 Proprotein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）抑制剂和入射2型糖尿病：系统评价和荟萃分析超过96,000例患者年。糖尿病护理2018; 41：364-367

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years

摘要

著录项

相似文献

相关主题

期刊订阅